Preventing Acquired Resistance: Strengthen TB Treatment by Adding Amikacin in the First Treatment Week of Multidrug-resistant Tuberculosis

PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

March 31, 2024

Study Completion Date

February 28, 2026

Conditions
Tuberculosis, Multidrug-Resistant
Interventions
DRUG

Amikacin

"In addition to the all-oral RR-TB treatment, add two intramuscular doses each consisting of 30 mg amikacin/kg, a first dose on day 1 and a second dose on day 4, all in the first week of treatment.~The amikacin solution will be admixed with a lidocaine solution in the syringe before administration."

Trial Locations (1)

Unknown

RECRUITING

Kabutare hospital, Kabutare

All Listed Sponsors
collaborator

Institute of Tropical Medicine

OTHER_GOV

collaborator

World Health Organization

OTHER

lead

Rwanda Biomedical Centre

OTHER